Literature DB >> 11935259

Postischemic hyperthermia induces Alzheimer-like pathology in the rat brain.

R Sinigaglia-Coimbra1, E A Cavalheiro, C G Coimbra.   

Abstract

This study addresses the effects of induced hyperthermia on post-ischemic rat brain evaluated histologically and/or immunohistochemically after 7-day, 2-month or 6-month survival. Hyperthermia (38.5 degrees - 40 degrees C) maintained (by heating the cage environment to 34-35 degrees C) for two consecutive periods of 5 and 9 h timed, respectively, from 4- and 21-h recirculation following 10-min global ischemia (two-vessel occlusion + hypotension) induced chronic neuronal death that became apparent in the rat forebrain from 7-day to 2-month survival. Associated immunohistochemical findings after 2 or 6 months of recovery included: (1) complement activation (membrane attack complex formation); (2) generalized overexpression of ubiquitin in surviving forebrain neurons; (3) persistent activation of macrophages; (4) presence of gemistocytic astrocytes in the hippocampus; (5) maturation of amyloid plaques (identified by immunohistochemistry using anti-human beta-A4 primary antibody) in cerebral cortex; and (6) intracellular deposits identified by anti-human hyperphosphorylated tau protein antibodies. This novel non-transgenic, self-sustained model of neurodegeneration triggered by the association of two prevalent insults to the aging human brain (ischemia and hyperthermia) presents morphological features similar to those of Alzheimer's disease. This finding raises the possibility that febrile complications of acute brain injuries may similarly impair human cognitive function in the long run.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11935259     DOI: 10.1007/s00401-001-0487-3

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  26 in total

1.  Endovascular middle cerebral artery occlusion in rats as a model for studying vascular dementia.

Authors:  Shao-Hua Yang; Ritu A Shetty; Ran Liu; Nathalie Sumien; Kevin R Heinrich; Margaret Rutledge; Nopporn Thangthaeng; Anne-Marie Brun-Zinkernagel; Michael J Forster
Journal:  Age (Dordr)       Date:  2006-12-02

2.  Measurement by ELISA of complement factor 4 (C4) in the rat brain: necessity for removal of cerebrovascular proteins.

Authors:  David A Loeffler; Dianne M Camp
Journal:  Neurochem Res       Date:  2006-07-18       Impact factor: 3.996

3.  Reversal of temperature-induced conformational changes in the amyloid-beta peptide, Abeta40, by the beta-sheet breaker peptides 16-23 and 17-24.

Authors:  Funda F Bölükbaşi Hatip; Midori Suenaga; Tatsuo Yamada; Yoichi Matsunaga
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

Review 4.  Environmental factors in the development and progression of late-onset Alzheimer's disease.

Authors:  Moses N Wainaina; Zhichun Chen; Chunjiu Zhong
Journal:  Neurosci Bull       Date:  2014-03-24       Impact factor: 5.203

5.  Environmental factors preceding aβ40 monomer to oligomers and the detection of oligomers in Alzheimer's disease patient serum.

Authors:  Yoichi Matsunaga; Midori Suenaga
Journal:  J Amino Acids       Date:  2012-02-08

Review 6.  Brain ischemia activates β- and γ-secretase cleavage of amyloid precursor protein: significance in sporadic Alzheimer's disease.

Authors:  Ryszard Pluta; Wanda Furmaga-Jabłońska; Ryszard Maciejewski; Marzena Ułamek-Kozioł; Mirosław Jabłoński
Journal:  Mol Neurobiol       Date:  2012-10-19       Impact factor: 5.590

7.  Using animal models to determine the significance of complement activation in Alzheimer's disease.

Authors:  David A Loeffler
Journal:  J Neuroinflammation       Date:  2004-10-12       Impact factor: 8.322

Review 8.  Proteomics in Traditional Chinese Medicine with an Emphasis on Alzheimer's Disease.

Authors:  Yanuar Alan Sulistio; Klaus Heese
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-18       Impact factor: 2.629

Review 9.  Sporadic Alzheimer's disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer's disease genes.

Authors:  Ryszard Pluta; Mirosław Jabłoński; Marzena Ułamek-Kozioł; Janusz Kocki; Judyta Brzozowska; Sławomir Januszewski; Wanda Furmaga-Jabłońska; Anna Bogucka-Kocka; Ryszard Maciejewski; Stanisław J Czuczwar
Journal:  Mol Neurobiol       Date:  2013-03-22       Impact factor: 5.590

Review 10.  Modeling Alzheimer's disease in transgenic rats.

Authors:  Sonia Do Carmo; A Claudio Cuello
Journal:  Mol Neurodegener       Date:  2013-10-25       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.